Endocrine Management of Prostatic Cancer
1st Edition
Published on 4. June 2019
VI, 137 pages
978-3-11-085367-4 (ISBN)
Description
Keine ausführliche Beschreibung für "Endocrine Management of Prostatic Cancer" verfügbar.
More details
Other editions
Additional editions
H. Klosterhalfen
Endocrine Management of Prostatic Cancer
Book
04/1988
1st Edition
De Gruyter
€119.95
Shipment within 7-9 days
Content
- Intro
- Contents
- I. Mechanism of hormonal action at cellular level and biochemistry
- Mechanism and effects of androgen withdrawal therapies
- Target-cell response to androgen withdrawal
- Effects of chronic treatment with an LH-RH agonist on human testis tissue
- Animal models for prostate cancer
- The significance of the nude mice model for studies on human prostatic carcinoma
- II. Etiology and experimental basis of therapy
- Etiology and natural history of early prostatic cancer
- Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists
- III. Clinics
- Evaluation of different endocrine approaches in the treatment of prostatic carcinoma
- Rationale of total androgen blockade by cyproterone acetate
- Clinical experience with Androcur⊃&® &/sup∈ the treatment of prostatic cancer
- Prostate cancer treatment: tolerance of different endocrine regimens
- Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients
- Results and experience with the androgen ablation therapy: current trends in the USA
- Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate
- List of first-mentioned contributors
